Is breast-conserving therapy in the genetically predisposed breast cancer patient a reasonable and appropriate option?

This publication has 22 references indexed in Scilit:

• Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy
  European Journal Of Cancer, 2004
• The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer
  Seminars in Radiation Oncology, 2002
• Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation
  New England Journal of Medicine, 2001
• Involvement of Brca1 in S-Phase and G₂-Phase Checkpoints after Ionizing Irradiation
  Molecular and Cellular Biology, 2001
• BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines
  Journal of Biological Chemistry, 2000
• Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient Cells
  Molecular Cell, 1999
• Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
  New England Journal of Medicine, 1999
• A targeted disruption of the murine Brca1 gene causes γ-irradiation hypersensitivity and genetic instability
  Oncogene, 1998
• Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
  Nature, 1997
• The genetics of breast and ovarian cancer
  British Journal of Cancer, 1995